• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X肽,一种源自乙肝病毒的新型细胞穿透肽基序。

X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.

作者信息

Montrose Kristopher, Yang Yi, Krissansen Geoffrey W

机构信息

Department of Molecular Medicine & Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Department of Molecular Medicine & Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

出版信息

Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-8. doi: 10.1016/j.bbrc.2014.09.057. Epub 2014 Sep 22.

DOI:10.1016/j.bbrc.2014.09.057
PMID:25251474
Abstract

Cell-penetrating peptides (CPPs) are able to penetrate the plasma membrane and gain access to the interior of any replicating or non-replicating cell, and are being considered as drug delivery agents. Here we describe the serendipitous discovery of a novel CPP motif (MAARLCCQ), designated X-pep, located at the extreme N-terminus of the X-protein of the hepatitis B virus. X-pep, and a C-terminally truncated form of the peptide (MAARL), readily penetrated HepG2 cells. Further truncation by removal of the terminal leucine residue impaired the cell-penetrating activity of peptide, indicating that MAARL is the active core of the peptide. X-pep is located adjacent to another CPP, namely Xentry, and like Xentry is unable to penetrate unactivated resting lymphocytes suggesting selective cell uptake. A D-isomeric form of the MAARL peptide was not cell-permeable, indicating that the cell-penetrating function of the peptide involves stereoselective interaction with a chiral receptor. The discovery of X-pep, which bears no resemblance to known CPPs, allows studies to be undertaken to determine additional characteristics of this novel CPP.

摘要

细胞穿透肽(CPPs)能够穿透质膜并进入任何正在复制或非复制细胞的内部,正被视为药物递送剂。在此,我们描述了一个位于乙型肝炎病毒X蛋白极端N端的新型CPP基序(MAARLCCQ)的意外发现,该基序被命名为X-肽。X-肽以及该肽的C端截短形式(MAARL)能够轻易穿透HepG2细胞。通过去除末端亮氨酸残基进一步截短会损害该肽的细胞穿透活性,这表明MAARL是该肽的活性核心。X-肽与另一种CPP即Xentry相邻,并且与Xentry一样无法穿透未活化的静止淋巴细胞,提示存在选择性细胞摄取。MAARL肽的D-异构体形式不具有细胞渗透性,这表明该肽的细胞穿透功能涉及与手性受体的立体选择性相互作用。X-肽的发现与已知的CPPs没有相似之处,这使得我们能够开展研究以确定这种新型CPP的其他特性。

相似文献

1
X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus.X肽,一种源自乙肝病毒的新型细胞穿透肽基序。
Biochem Biophys Res Commun. 2014 Oct 10;453(1):64-8. doi: 10.1016/j.bbrc.2014.09.057. Epub 2014 Sep 22.
2
Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.利用生物信息学方法探索 SARS-CoV-2 蛋白质组中的新型有效穿透细胞肽。
PLoS One. 2021 Feb 19;16(2):e0247396. doi: 10.1371/journal.pone.0247396. eCollection 2021.
3
Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.基于登革热病毒衣壳蛋白的细胞穿透肽的核酸递送:设计与作用机制。
FEBS J. 2014 Jan;281(1):191-215. doi: 10.1111/febs.12587. Epub 2013 Nov 28.
4
Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems.量化细胞穿透肽-货物超分子复合物在脂质膜中的分子分配:优化基于肽的药物传递系统。
J Pept Sci. 2013 Apr;19(4):182-9. doi: 10.1002/psc.2477. Epub 2013 Jan 16.
5
The tetrapeptide core of the carrier peptide Xentry is cell-penetrating: novel activatable forms of Xentry.载体肽Xentry的四肽核心具有细胞穿透性:Xentry的新型可激活形式。
Sci Rep. 2014 May 9;4:4900. doi: 10.1038/srep04900.
6
Design of a PROTAC that antagonizes and destroys the cancer-forming X-protein of the hepatitis B virus.
Biochem Biophys Res Commun. 2014 Oct 31;453(4):735-40. doi: 10.1016/j.bbrc.2014.10.006. Epub 2014 Oct 8.
7
CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.CyLoP-1:一种新型富含半胱氨酸的细胞穿透肽,可将货物递送至细胞浆。
Bioconjug Chem. 2011 Mar 16;22(3):319-28. doi: 10.1021/bc100045s. Epub 2011 Feb 14.
8
Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.第二代富含精氨酸的 (R-X'-R)(4) 型细胞穿透性 α-ω-α 肽,含有受限的手性 ω-氨基酸 (X'),用于增强货物递送至细胞。
Bioorg Med Chem Lett. 2014 Sep 1;24(17):4198-202. doi: 10.1016/j.bmcl.2014.07.040. Epub 2014 Jul 19.
9
Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs.Xentry,一种新型的细胞穿透肽,专门用于药物传递。
Sci Rep. 2013;3:1661. doi: 10.1038/srep01661.
10
A peptide carrier for the delivery of elastin into fibroblast cells.弹性蛋白肽载体递送至成纤维细胞。
Int J Dermatol. 2012 Aug;51(8):923-9. doi: 10.1111/j.1365-4632.2011.05214.x.

引用本文的文献

1
Exploring the Chemical Features and Biomedical Relevance of Cell-Penetrating Peptides.探索细胞穿透肽的化学特性及生物医学相关性。
Int J Mol Sci. 2024 Dec 25;26(1):59. doi: 10.3390/ijms26010059.
2
Cell Penetrating Peptides Used in Delivery of Therapeutic Oligonucleotides Targeting Hepatitis B Virus.用于递送靶向乙型肝炎病毒的治疗性寡核苷酸的细胞穿透肽
Pharmaceuticals (Basel). 2020 Dec 21;13(12):483. doi: 10.3390/ph13120483.
3
Cell-penetrating peptide-mediated cell entry of H5N1 highly pathogenic avian influenza virus.细胞穿透肽介导的 H5N1 高致病性禽流感病毒进入细胞。
Sci Rep. 2020 Oct 22;10(1):18008. doi: 10.1038/s41598-020-74604-w.
4
Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.解析严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的蛋白质组,寻找参与发病机制或可用作药物递送载体的细胞穿透肽。
Infect Genet Evol. 2020 Nov;85:104474. doi: 10.1016/j.meegid.2020.104474. Epub 2020 Jul 24.
5
Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway.细胞穿透肽作为抗病毒药物和靶向肝病毒复制途径的肽核酸递药载体的研究进展。
Biomolecules. 2018 Jul 16;8(3):55. doi: 10.3390/biom8030055.
6
Drug Delivery Strategies for Antivirals against Hepatitis B Virus.抗病毒药物的药物递送策略用于乙型肝炎病毒。
Viruses. 2018 May 17;10(5):267. doi: 10.3390/v10050267.